Dexmedetomidine post‐treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF‐1α signalling
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dexmedetomidine post‐treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF‐1α signalling
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-11-04
DOI
10.1111/jcmm.14795
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
- (2019) Tarja Alakoski et al. BASIC RESEARCH IN CARDIOLOGY
- Dexmedetomidine attenuates lung apoptosis induced by renal ischemia–reperfusion injury through α2AR/PI3K/Akt pathway
- (2018) Juanjuan Li et al. Journal of Translational Medicine
- Protection of Dexmedetomidine Against Ischemia/Reperfusion-Induced Apoptotic Insults to Neuronal Cells Occurs Via an Intrinsic Mitochondria-Dependent Pathway
- (2017) Gong-Jhe Wu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway
- (2017) Jing-jing Zhang et al. PLoS One
- Dexmedetomidine Protects Mouse Brain from Ischemia-Reperfusion Injury via Inhibiting Neuronal Autophagy through Up-Regulating HIF-1α
- (2017) Cong Luo et al. Frontiers in Cellular Neuroscience
- Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes
- (2017) Ke Peng et al. Experimental and Therapeutic Medicine
- The cardioprotective effect of dihydromyricetin prevents ischemia–reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways
- (2016) Shasha Liu et al. APOPTOSIS
- Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury
- (2016) XIANG YANG CHENG et al. Molecular Medicine Reports
- Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism
- (2016) Jaime A. Riquelme et al. PHARMACOLOGICAL RESEARCH
- Dexmedetomidine Attenuates Blood-Spinal Cord Barrier Disruption Induced by Spinal Cord Ischemia Reperfusion Injury in Rats
- (2015) Bo Fang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Reducing myocardial infarct size: challenges and future opportunities
- (2015) Heerajnarain Bulluck et al. HEART
- Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain
- (2015) Mun Chiang Chan et al. PLoS One
- The efficacy and mechanism of dexmedetomidine in myocardial apoptosis via the renin–angiotensin–aldosterone system
- (2014) Huishu Wang et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- HIF-1α Signaling Activation by Post-Ischemia Treatment with Astragaloside IV Attenuates Myocardial Ischemia-Reperfusion Injury
- (2014) Jingwen Si et al. PLoS One
- Perioperative Dexmedetomidine Improves Outcomes of Cardiac Surgery
- (2013) Fuhai Ji et al. CIRCULATION
- C1q/Tumor Necrosis Factor-Related Protein-9, a Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling in the Ischemic Mouse Heart via Protein Kinase A Activation
- (2013) Y. Sun et al. CIRCULATION
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
- (2013) Z. Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart
- (2012) Mauricio Ibacache et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cardioprotection during cardiac surgery
- (2012) D. J. Hausenloy et al. CARDIOVASCULAR RESEARCH
- Direct Protective Effects of Dexmedetomidine Against Myocardial Ischemia-Reperfusion Injury in Anesthetized Pigs
- (2012) Osamu Yoshitomi et al. SHOCK
- Effect of hypoxia-inducible factor 1-alpha on hypoxia/reoxygenation-induced apoptosis in primary neonatal rat cardiomyocytes
- (2011) Xiaoou Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance
- (2010) Russell S. Whelan et al. Annual Review of Physiology
- Dipeptidyl-Quinolone Derivatives Inhibit Hypoxia Inducible Factor-1α Prolyl Hydroxylases-1, -2, and -3 with Altered Selectivity
- (2010) Justin K. Murray et al. JOURNAL OF COMBINATORIAL CHEMISTRY
- Deterioration of myocardial injury due to dexmedetomidine administration after myocardial ischaemia
- (2010) Soichiro Mimuro et al. RESUSCITATION
- An Updated Focused Review of Dexmedetomidine in Adults
- (2009) Anthony T Gerlach et al. ANNALS OF PHARMACOTHERAPY
- Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1α
- (2009) Huan-Xin Zhao et al. BASIC RESEARCH IN CARDIOLOGY
- HIF-1 regulation: not so easy come, easy go
- (2008) Mei Yee Koh et al. TRENDS IN BIOCHEMICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More